Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Bipolar radiofrequency ablation of refractory ventricular arrhythmias: results from a multicentre network

P. Futyma, A. Sultan, Ł. Zarębski, G. Imnadze, V. Maslova, S. Bordignon, M. Kousta, S. Knecht, N. Pavlović, P. Peichl, E. Lian, T. Kueffer, D. Scherr, M. Pfeffer, P. Moskal, G. Cismaru, B. Antolič, P. Wałek, S. Chen, M. Martinek, G. Kollias, M....

. 2024 ; 26 (10) : . [pub] 20241003

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, multicentrická studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc25003951

Grantová podpora
European Heart Rhythm Association Scientific Initiatives Committee
EHRA-SIC

AIMS: Advanced ablation strategies are needed to treat ventricular tachycardia (VT) and premature ventricular complexes (PVC) refractory to standard unipolar radiofrequency ablation (Uni-RFA). Bipolar radiofrequency catheter ablation (Bi-RFA) has emerged as a treatment option for refractory VT and PVC. Multicentre registry data on the use of Bi-RFA in the setting of refractory VT and PVC are lacking. The aim of this Bi-RFA registry is to determine its real-world safety, feasibility, and efficacy in patients with refractory VT/PVC. METHODS AND RESULTS: Consecutive patients undergoing Bi-RFA at 16 European centres for recurring VT/PVC after at least one standard Uni-RFA were included. Second ablation catheter was used instead of a dispersive patch and was positioned at the opposite site of the ablation target. Between March 2021 and August 2024, 91 patients underwent 94 Bi-RFA procedures (74 males, age 62 ± 13, and prior Uni-RFA range 1-8). Indications were recurrence of PVC (n = 56), VT (n = 20), electrical storm (n = 13), or PVC-triggered ventricular fibrillation (n = 2). Procedural time was 160 ± 73 min, Bi-RFA time 426 ± 286 s, and mean Uni-RFA time 819 ± 697 s. Elimination of clinical VT/PVC was achieved in 67 (74%) patients and suppression of VT/PVC in a further 10 (11%) patients. In the remaining 14 patients (15%), no effect on VT/PVC was observed. Three major complications occurred: coronary artery occlusion, atrioventricular block, and arteriovenous fistula. Follow-up lasted 7 ± 8 months. Nineteen patients (61%) remained VT free. ≥80% PVC burden reduction was achieved in 45 (78%). CONCLUSION: These real-world registry data indicate that Bi-RFA appears safe, is feasible, and is effective in the majority of patients with VT/PVC.

1st Clinic of Cardiology and Electrotherapy Swietokrzyskie Cardiology Centre Kielce Poland

1st Department of Cardiology Interventional Electrocardiology and Hypertension Jagiellonian University Medical College Krakow Poland

5th Department of Internal Medicine Cardiology Rehabilitation Iuliu Hatieganu University of Medicine and Pharmacy of Cluj Napoca Cluj Napoca Romania

Cardioangiologisches Centrum Bethanien Department Kardiologie Markus Krankenhaus Frankfurt Germany

Cardiovascular Research Institute Basel University Hospital Basel Basel Switzerland

Clinic for Electrophysiology Herz und Diabeteszentrum NRW Ruhr Universitaet Bochum Bad Oeynhausen Germany

Clinical Electrophysiology Hospital of the University of Pennsylvania Philadelphia Pennsylvania USA

Clinical Electrophysiology St Joseph's Heart Rhythm Center University of Rzeszów Anny Jagiellonki 17 35 623 Rzeszów Poland

Collegium Medicum Jan Kochanowski University Kielce Poland

Department for Cardiovascular Medicine University Hospital Dubrava Zagreb Croatia

Department of Cardiology Inselspital Bern University Hospital University of Bern Bern Switzerland

Department of Cardiology Institute for Clinical and Experimental Medicine Prague Czech Republic

Department of Cardiology University Hospital Basel Basel Switzerland

Department of Cardiology University Medical Centre of Ljubljana Ljubljana Slovenia

Department of Internal Medicine 2 Cardiology Angiology and Intensive Care Medicine Ordensklinikum Linz Elisabethinen Linz Austria

Department of Internal Medicine 3 Kiel Germany

Department of Internal Medicine Cardiology and Nephrology Hospital Wiener Neustadt Wiener Neustadt Austria

Division of Cardiology Department of Medicine Medical University of Graz Graz Austria

Heart Center Department of Electrophysiology University Hospital Cologne Cologne Germany

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003951
003      
CZ-PrNML
005      
20250206104821.0
007      
ta
008      
250121s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/europace/euae248 $2 doi
035    __
$a (PubMed)39331050
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Futyma, Piotr $u Clinical Electrophysiology, St. Joseph's Heart Rhythm Center, University of Rzeszów, Anny Jagiellonki 17, 35-623 Rzeszów, Poland $1 https://orcid.org/0000000302197612
245    10
$a Bipolar radiofrequency ablation of refractory ventricular arrhythmias: results from a multicentre network / $c P. Futyma, A. Sultan, Ł. Zarębski, G. Imnadze, V. Maslova, S. Bordignon, M. Kousta, S. Knecht, N. Pavlović, P. Peichl, E. Lian, T. Kueffer, D. Scherr, M. Pfeffer, P. Moskal, G. Cismaru, B. Antolič, P. Wałek, S. Chen, M. Martinek, G. Kollias, M. Derndorfer, S. Seidl, B. Schmidt, J. Lüker, D. Steven, P. Sommer, M. Jastrzębski, J. Kautzner, T. Reichlin, C. Sticherling, H. Pürerfellner, A. Enriquez, J. Wörmann, JKR. Chun
520    9_
$a AIMS: Advanced ablation strategies are needed to treat ventricular tachycardia (VT) and premature ventricular complexes (PVC) refractory to standard unipolar radiofrequency ablation (Uni-RFA). Bipolar radiofrequency catheter ablation (Bi-RFA) has emerged as a treatment option for refractory VT and PVC. Multicentre registry data on the use of Bi-RFA in the setting of refractory VT and PVC are lacking. The aim of this Bi-RFA registry is to determine its real-world safety, feasibility, and efficacy in patients with refractory VT/PVC. METHODS AND RESULTS: Consecutive patients undergoing Bi-RFA at 16 European centres for recurring VT/PVC after at least one standard Uni-RFA were included. Second ablation catheter was used instead of a dispersive patch and was positioned at the opposite site of the ablation target. Between March 2021 and August 2024, 91 patients underwent 94 Bi-RFA procedures (74 males, age 62 ± 13, and prior Uni-RFA range 1-8). Indications were recurrence of PVC (n = 56), VT (n = 20), electrical storm (n = 13), or PVC-triggered ventricular fibrillation (n = 2). Procedural time was 160 ± 73 min, Bi-RFA time 426 ± 286 s, and mean Uni-RFA time 819 ± 697 s. Elimination of clinical VT/PVC was achieved in 67 (74%) patients and suppression of VT/PVC in a further 10 (11%) patients. In the remaining 14 patients (15%), no effect on VT/PVC was observed. Three major complications occurred: coronary artery occlusion, atrioventricular block, and arteriovenous fistula. Follow-up lasted 7 ± 8 months. Nineteen patients (61%) remained VT free. ≥80% PVC burden reduction was achieved in 45 (78%). CONCLUSION: These real-world registry data indicate that Bi-RFA appears safe, is feasible, and is effective in the majority of patients with VT/PVC.
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé středního věku $7 D008875
650    12
$a komorová tachykardie $x chirurgie $x patofyziologie $7 D017180
650    12
$a komorové extrasystoly $x chirurgie $x patofyziologie $x diagnóza $7 D018879
650    12
$a katetrizační ablace $x metody $7 D017115
650    _2
$a senioři $7 D000368
650    12
$a registrace $7 D012042
650    12
$a recidiva $7 D012008
650    _2
$a výsledek terapie $7 D016896
650    _2
$a studie proveditelnosti $7 D005240
651    _2
$a Evropa $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Sultan, Arian $u Heart Center, Department of Electrophysiology, University Hospital Cologne, Cologne, Germany $1 https://orcid.org/0000000318074860
700    1_
$a Zarębski, Łukasz $u Clinical Electrophysiology, St. Joseph's Heart Rhythm Center, University of Rzeszów, Anny Jagiellonki 17, 35-623 Rzeszów, Poland $1 https://orcid.org/0000000325247950
700    1_
$a Imnadze, Guram $u Clinic for Electrophysiology, Herz- und Diabeteszentrum NRW, Ruhr-Universitaet Bochum, Bad Oeynhausen, Germany $1 https://orcid.org/0000000328394454
700    1_
$a Maslova, Vera $u Department of Internal Medicine III (Cardiology and Intensive Care Medicine), University Hospital Schleswig-Holstein (UKSH), Kiel, Germany $1 https://orcid.org/000900060647767X
700    1_
$a Bordignon, Stefano $u Cardioangiologisches Centrum Bethanien, Department Kardiologie, Markus Krankenhaus, Frankfurt, Germany $1 https://orcid.org/0000000202824658
700    1_
$a Kousta, Maria $u Department of Internal Medicine II, Cardiology, Angiology, and Intensive Care Medicine, Ordensklinikum Linz Elisabethinen, Linz, Austria
700    1_
$a Knecht, Sven $u Department of Cardiology, University Hospital Basel, Basel, Switzerland $u Cardiovascular Research Institute Basel, University Hospital Basel, Basel, Switzerland $1 https://orcid.org/000000017122021X
700    1_
$a Pavlović, Nikola $u Department for Cardiovascular Medicine, University Hospital Dubrava, Zagreb, Croatia $1 https://orcid.org/0000000191877681
700    1_
$a Peichl, Petr $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $1 https://orcid.org/0000000256250071 $7 xx0092197
700    1_
$a Lian, Evgeny $u Department of Internal Medicine III (Cardiology and Intensive Care Medicine), University Hospital Schleswig-Holstein (UKSH), Kiel, Germany $1 https://orcid.org/0000000196969227
700    1_
$a Kueffer, Thomas $u Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland $1 https://orcid.org/0000000335534945
700    1_
$a Scherr, Daniel $u Division of Cardiology, Department of Medicine, Medical University of Graz, Graz, Austria $1 https://orcid.org/0000000158685493
700    1_
$a Pfeffer, Michael $u Department of Internal Medicine, Cardiology and Nephrology, Hospital Wiener Neustadt, Wiener Neustadt, Austria
700    1_
$a Moskal, Paweł $u 1st Department of Cardiology, Interventional Electrocardiology, and Hypertension, Jagiellonian University Medical College, Krakow, Poland $1 https://orcid.org/0000000156445963
700    1_
$a Cismaru, Gabriel $u 5th Department of Internal Medicine, Cardiology Rehabilitation, Iuliu Hatieganu University of Medicine and Pharmacy of Cluj Napoca, Cluj Napoca, Romania $1 https://orcid.org/0000000273529584
700    1_
$a Antolič, Bor $u Department of Cardiology, University Medical Centre of Ljubljana, Ljubljana, Slovenia $1 https://orcid.org/0000000254823809
700    1_
$a Wałek, Paweł $u 1st Clinic of Cardiology and Electrotherapy, Swietokrzyskie Cardiology Centre, Kielce, Poland $u Collegium Medicum, Jan Kochanowski University, Kielce, Poland $1 https://orcid.org/0000000306326573
700    1_
$a Chen, Shaojie $u Cardioangiologisches Centrum Bethanien, Department Kardiologie, Markus Krankenhaus, Frankfurt, Germany $1 https://orcid.org/0000000270829573
700    1_
$a Martinek, Martin $u Department of Internal Medicine II, Cardiology, Angiology, and Intensive Care Medicine, Ordensklinikum Linz Elisabethinen, Linz, Austria $1 https://orcid.org/0000000288958488
700    1_
$a Kollias, Georgios $u Department of Internal Medicine II, Cardiology, Angiology, and Intensive Care Medicine, Ordensklinikum Linz Elisabethinen, Linz, Austria $1 https://orcid.org/0000000187699157
700    1_
$a Derndorfer, Michael $u Department of Internal Medicine II, Cardiology, Angiology, and Intensive Care Medicine, Ordensklinikum Linz Elisabethinen, Linz, Austria $1 https://orcid.org/0000000206850845
700    1_
$a Seidl, Sebastian $u Department of Internal Medicine II, Cardiology, Angiology, and Intensive Care Medicine, Ordensklinikum Linz Elisabethinen, Linz, Austria
700    1_
$a Schmidt, Boris $u Cardioangiologisches Centrum Bethanien, Department Kardiologie, Markus Krankenhaus, Frankfurt, Germany $1 https://orcid.org/0000000153479906
700    1_
$a Lüker, Jakob $u Heart Center, Department of Electrophysiology, University Hospital Cologne, Cologne, Germany $1 https://orcid.org/0000000346672200
700    1_
$a Steven, Daniel $u Heart Center, Department of Electrophysiology, University Hospital Cologne, Cologne, Germany $1 https://orcid.org/0000000168395895
700    1_
$a Sommer, Philipp $u Clinic for Electrophysiology, Herz- und Diabeteszentrum NRW, Ruhr-Universitaet Bochum, Bad Oeynhausen, Germany $1 https://orcid.org/0000000230378704
700    1_
$a Jastrzębski, Marek $u 1st Department of Cardiology, Interventional Electrocardiology, and Hypertension, Jagiellonian University Medical College, Krakow, Poland $1 https://orcid.org/0000000233186601
700    1_
$a Kautzner, Josef $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $1 https://orcid.org/0000000216326182 $7 xx0037112
700    1_
$a Reichlin, Tobias $u Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland $1 https://orcid.org/0000000271978415
700    1_
$a Sticherling, Christian $u Department of Cardiology, University Hospital Basel, Basel, Switzerland $u Cardiovascular Research Institute Basel, University Hospital Basel, Basel, Switzerland $1 https://orcid.org/0000000184287050
700    1_
$a Pürerfellner, Helmut $u Department of Internal Medicine II, Cardiology, Angiology, and Intensive Care Medicine, Ordensklinikum Linz Elisabethinen, Linz, Austria $1 https://orcid.org/0000000289658495
700    1_
$a Enriquez, Andres $u Clinical Electrophysiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA $1 https://orcid.org/000000028146360X
700    1_
$a Wörmann, Jonas $u Heart Center, Department of Electrophysiology, University Hospital Cologne, Cologne, Germany $1 https://orcid.org/0000000222138946
700    1_
$a Chun, Julian K R $u Cardioangiologisches Centrum Bethanien, Department Kardiologie, Markus Krankenhaus, Frankfurt, Germany $1 https://orcid.org/0000000223556015
773    0_
$w MED00149837 $t Europace $x 1532-2092 $g Roč. 26, č. 10 (2024)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39331050 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104816 $b ABA008
999    __
$a ok $b bmc $g 2263600 $s 1239958
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 26 $c 10 $e 20241003 $i 1532-2092 $m Europace $n Europace $x MED00149837
GRA    __
$p European Heart Rhythm Association Scientific Initiatives Committee
GRA    __
$p EHRA-SIC
LZP    __
$a Pubmed-20250121

Najít záznam

Citační ukazatele

Možnosti archivace